Safety and tolerability of a new formulation (90 mg/kg/day divided every 12 h) of amoxicillin/clavulanate (Augmentin) in the empiric treatment of pediatric acute otitis media caused by drug-resistant Streptococcus pneumoniae
Bottenfield, G W, Burch, D J, Hedrick, J A, Schaten, R, Rowinski, C A, Davies, J T
Published in The Pediatric infectious disease journal (01.10.1998)
Published in The Pediatric infectious disease journal (01.10.1998)
Get more information
Journal Article